Abstract We present data from a UK cohort of patients with alopecia areata (AA) who have sought Janus kinase inhibitor (JAKi) treatments prior to National Health Service funding. explored referral methods, access consultations, and shared care in monitoring acquisition medication both the abroad. looked at drugs dosage, adjuvant therapies response treatment, report on side-effects reasons for c...
